Ypsomed Holding AG (YPHDF)
OTCMKTS · Delayed Price · Currency is USD
374.82
-18.65 (-4.74%)
At close: Feb 5, 2026
Ypsomed Holding AG Revenue
Ypsomed Holding AG had revenue of 362.69M CHF in the half year ending September 30, 2025, with 42.01% growth. This brings the company's revenue in the last twelve months to 787.55M, up 27.63% year-over-year. In the fiscal year ending March 31, 2025, Ypsomed Holding AG had annual revenue of 748.87M with 36.54% growth.
Revenue (ttm)
787.55M CHF
Revenue Growth
+27.63%
P/S Ratio
5.36
Revenue / Employee
393.77K CHF
Employees
2,000
Market Cap
5.30B USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 748.87M | 200.41M | 36.54% |
| Mar 31, 2024 | 548.46M | 51.00M | 10.25% |
| Mar 31, 2023 | 497.46M | 32.62M | 7.02% |
| Mar 31, 2022 | 464.84M | 61.19M | 15.16% |
| Mar 31, 2021 | 403.66M | 9.39M | 2.38% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meihua International Medical Technologies | 89.55M |
| InnerScope Hearing Technologies | 14.51M |
| Encision | 6.30M |
| Lancer Orthodontics | 6.19M |
| Reflect Scientific | 1.72M |
| Ozop Energy Solutions | 323.50K |
| Standard Dental Labs | 306.82K |
| Cardiac Biotech Solutions | 50.37K |
Ypsomed Holding AG News
- 3 months ago - Ypsomed Holding AG (YPHDF) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ypsomed Holding AG 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Ypsomed Holding AG (XSWX:YPSN) (H1 2026) Earnings Call Highlights: Strong Growth in Delivery ... - GuruFocus
- 3 months ago - Half Year 2026 Ypsomed Holding AG Earnings Call Transcript - GuruFocus
- 4 months ago - Ypsomed To Establish Production Plant In US With CHF 200 Mln First Phase Investment - Nasdaq
- 4 months ago - Ypsomed Holding AG (YPHDF) Analyst/Investor Day - Slideshow - Seeking Alpha
- 1 year ago - Novo Nordisk (NVO) Partners with Ypsomed for Next-Gen Obesity Drug Delivery - GuruFocus
- 1 year ago - Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens - Seeking Alpha